Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.40 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CFTR | P13569 | 1/20 | 0.32 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8998614 | 0.96 | CYP2A6 (0.41) | CYP2A6TRIM24TRIM33ALDH1A1CYP1A2 | |
| SCHEMBL73117 | 0.95 | — | — | |
| SCHEMBL9989026 | 0.95 | — | — | |
| SCHEMBL501836 | 0.91 | — | — | |
| SCHEMBL9066344 | 0.91 | TRIM24 (0.50) | CYP2A6TRIM24TRIM33ALDH1A1CYP1A2 | |
| SCHEMBL9627922 | 0.91 | — | — | |
| SCHEMBL8022297 | 0.91 | TRIM24 (0.50) | CYP2A6TRIM24TRIM33ALDH1A1CYP1A2 | |
| SCHEMBL1431864 | 0.85 | — | — | |
| SCHEMBL232122 | 0.85 | — | — | |
| SCHEMBL11352253 | 0.84 | TRIM24 (0.53) | CYP2A6TRIM24TRIM33ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3160 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250271447-A1 | MULTIPLEXING HOMOCYSTEINE AND CYSTEINE IN FIRST-TIER SCREENING ASSAYS | US HEALTH (US) | 2025-08-28 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| CN-119746835-A | Bowl-shaped nanocomposite for capturing exosomes and preparation method and application thereof | 北京大学 | 2025-04-04 | — | — | CN | claimed |
| WO-2025068213-A1 | USE OF A MARKER SET FOR DETERMINING THE RISK OF HAVING OR DEVELOPING BLADDER CANCER | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| US-20250073321-A1 | Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and Disorders | UNIV NEW YORK (US) | 2025-03-06 | — | — | US | claimed |
| EP-4511658-A1 | MULTIPLEXING HOMOCYSTEINE AND CYSTEINE IN FIRST-TIER SCREENING ASSAYS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2025-02-26 | — | — | EP | claimed |
| CN-118155825-A | Diagnosis and treatment of rhabdomyolysis-induced acute kidney injury | 上海美瑞科生物科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-116386716-B | Metabolomics and methods for gastric cancer diagnosis | 浙江省肿瘤医院 | 2024-03-15 | — | — | CN | claimed |
| CN-117074589-A | Method for detecting succinylacetone, amino acid and carnitine in maternal amniotic fluid | 山东英盛生物技术有限公司 | 2023-11-17 | — | — | CN | claimed |
| US-5104898-A | Administering succinylacetone(4,6-dioxoheptanoic acid) | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-04-14 | — | — | US | claimed |
| EP-0413757-A4 | METHOD FOR TREATING AUTOIMMUNE DISEASE USING SUCCINYLACETONE | US HEALTH (US) | 1991-06-12 | — | — | EP | claimed |
| WO-1991004734-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING 4,6-TIOXOHEPTANOIC ACID OR ITS DERIVATIVES | CETUS CORPORATION (US) | 1991-04-18 | — | — | WO | claimed |
| WO-1991003455-A1 | PROCESS FOR MAKING SUCCINYL ACETONE | CETUS CORPORATION (US) | 1991-03-21 | — | — | WO | claimed |
| EP-0413757-A1 | METHOD FOR TREATING AUTOIMMUNE DISEASE USING SUCCINYLACETONE | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1991-02-27 | — | — | EP | claimed |
| WO-1991001726-A1 | METHOD OF PREVENTING GRAFT REJECTION IN SOLID ORGAN TRANSPLANTATION | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-02-21 | — | — | WO | claimed |
| US-4895872-A | TREATING HYPERACTIVE IMMUNE SYSTEMS; AUTOIMMUNE AND GRAFT/HOST DISEASES | CETUS CORPORATION (US) | 1990-01-23 | — | — | US | claimed |
| WO-1990000049-A2 | IMMUNOSUPPRESSIVE ANALOGUES AND DERIVATIVES OF SUCCINYLACETONE | CETUS CORPORATION (US) | 1990-01-11 | — | — | WO | claimed |
| WO-1989010742-A1 | METHOD FOR TREATING AUTOIMMUNE DISEASE USING SUCCINYLACETONE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (US) | 1989-11-16 | — | — | WO | claimed |
| US-4670467-A | SUCCINYLACETONE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1987-06-02 | — | — | US | claimed |